Prevention of bone loss by bisphosphonate YM175 in ovariectomized dogs with dietary calcium restriction. | Jpn J Pharmacol;71(3): 239-46, 1996 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Prevention of bone loss by bisphosphonate YM175 in ovariectomized dogs with dietary calcium restriction.

Motoie, H; Kanoh, H; Ogata, S; Kawamuki, K; Shikama, H; Fujikura, T.

Affiliation

Motoie H; Endocrinology and Metabolic Disease Research Laboratory, Yamanouchi Pharmaceutical Co., Ltd. Ibaraki, Japan.

Jpn J Pharmacol ; 71(3): 239-46, 1996 Jul.

Article in En | MEDLINE | ID: mdl-8854206

Subject(s)

Calcium, Dietary/administration & dosage; Diphosphonates/pharmacology; Osteoporosis/prevention & control; Animals; Bone Density/drug effects; Calcitriol/blood; Dogs; Female; Hydroxyproline/urine; Ovariectomy

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Calcium, Dietary / Diphosphonates Limits: Animals Language: En Journal: Jpn J Pharmacol Year: 1996 Document type: Article Affiliation country: Japan

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Calcium, Dietary / Diphosphonates Limits: Animals Language: En Journal: Jpn J Pharmacol Year: 1996 Document type: Article Affiliation country: Japan